BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 19428827)

  • 1. Australia's national Q fever vaccination program.
    Gidding HF; Wallace C; Lawrence GL; McIntyre PB
    Vaccine; 2009 Mar; 27(14):2037-41. PubMed ID: 19428827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990.
    Ackland JR; Worswick DA; Marmion BP
    Med J Aust; 1994 Jun; 160(11):704-8. PubMed ID: 8202006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of Q fever in Australia 1991-1994.
    Garner MG; Longbottom HM; Cannon RM; Plant AJ
    Aust N Z J Public Health; 1997 Dec; 21(7):722-30. PubMed ID: 9489189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Q fever vaccination in Queensland abattoirs.
    Bell M; Patel M; Sheridan J
    Commun Dis Intell; 1997 Feb; 21(3):29-31. PubMed ID: 9079588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic evaluation of increased uptake in Q fever vaccination among meat and agricultural industry workers following implementation of the National Q Fever Management Program.
    Kermode M; Yong K; Hurley S; Marmion B
    Aust N Z J Public Health; 2003; 27(4):390-8. PubMed ID: 14705300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL; Waag DM
    Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a Q fever vaccination program for high-risk patients in the Netherlands.
    Isken LD; Kraaij-Dirkzwager M; Vermeer-de Bondt PE; Rümke HC; Wijkmans C; Opstelten W; Timen A
    Vaccine; 2013 May; 31(23):2617-22. PubMed ID: 23583810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A serosurvey of Coxiella burnetii infection in children and young adults in South West Queensland.
    Parker N; Robson J; Bell M
    Aust N Z J Public Health; 2010 Feb; 34(1):79-82. PubMed ID: 20920110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines against Coxiella infection.
    Zhang G; Samuel JE
    Expert Rev Vaccines; 2004 Oct; 3(5):577-84. PubMed ID: 15485337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare complication of Q fever vaccination.
    Fairweather P; O'Rourke T; Strutton G
    Australas J Dermatol; 2005 May; 46(2):124-5. PubMed ID: 15842410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control strategies for Q fever based on results of pre-vaccination screening in Victoria, 1988 to 2001.
    Greig JE; Patel MS; Clements MS; Taylor NK
    Aust N Z J Public Health; 2005 Feb; 29(1):53-7. PubMed ID: 15782873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Q-Vax Q fever vaccine failures, Victoria, Australia 1994-2013.
    Bond KA; Franklin LJ; Sutton B; Firestone SM
    Vaccine; 2017 Dec; 35(51):7084-7087. PubMed ID: 29132996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Q Fever Knowledge, Attitudes and Vaccination Status of Australia's Veterinary Workforce in 2014.
    Sellens E; Norris JM; Dhand NK; Heller J; Hayes L; Gidding HF; Willaby H; Wood N; Bosward KL
    PLoS One; 2016; 11(1):e0146819. PubMed ID: 26756210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Q fever vaccination of children in Australia: Limited experience to date.
    Armstrong M; Francis J; Robson J; Graves S; Mills D; Ferguson J; Nourse C
    J Paediatr Child Health; 2019 Sep; 55(9):1099-1102. PubMed ID: 30604569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Q fever in northern Greece: epidemiological and clinical data from 58 acute and chronic cases.
    Pape M; Mandraveli K; Arvanitidou-Vagiona M; Nikolaidis P; Alexiou-Daniel S
    Clin Microbiol Infect; 2009 Dec; 15 Suppl 2():150-1. PubMed ID: 19392895
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of vaccination by a phase I Coxiella burnetii-inactivated vaccine in goat herds in clinical Q fever situation.
    de Cremoux R; Rousset E; Touratier A; Audusseau G; Nicollet P; Ribaud D; David V; Le Pape M
    FEMS Immunol Med Microbiol; 2012 Feb; 64(1):104-6. PubMed ID: 22066485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Q fever risk exposure surveillance may permit better informed vaccination policy.
    Massey PD; Irwin M; Durrheim DN
    Commun Dis Intell Q Rep; 2009 Mar; 33(1):41-5. PubMed ID: 19618770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Q fever vaccine uptake in South Australian meat processors prior to the introduction of the National Q Fever Management Program.
    Milazzo A; Featherstone KB; Hall RG
    Commun Dis Intell Q Rep; 2005; 29(4):400-6. PubMed ID: 16465932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Q fever in the Netherlands from 2007 to 2010.
    Delsing CE; Kullberg BJ; Bleeker-Rovers CP
    Neth J Med; 2010 Dec; 68(12):382-7. PubMed ID: 21209463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Q fever trilogy morbidity--deadends--stark choices.
    Marmion BP
    Aust N Z J Public Health; 1997 Dec; 21(7):677-80. PubMed ID: 9489180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.